Largest health care companies — Page 7
The 1,019 US-listed companies in the health care sector, ranked by market capitalisation. Sector comes from each company's Nasdaq classification; revenue and earnings come from its SEC filings.
Combined market cap
$9.815 T
10.5% of all US-listed value
Companies
1,019
Ranked #4 of 12 sectors
Average
$9.632 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 601 | SkyAISKYA | $126.9M | $2.94 | -0.51% | United States |
| 602 | Apyx MedicalAPYX | $126.8M | $3.01 | +16.22% | United States |
| 603 | Yarrow BioscienceYARW | $126.1M | $13.55 | -9.12% | United States |
| 604 | Protara TherapeuticsTARA | $125.9M | $2.13 | -9.36% | United States |
| 605 | Compass TherapeuticsCMPX | $125.1M | $0.69 | -8.89% | United States |
| 606 | SolanaHSDT | $124.1M | $1.92 | -8.81% | United States |
| 607 | PDS BiotechnologyPDSB | $123.9M | $1.18 | -9.23% | United States |
| 608 | Spruce BiosciencesSPRB | $122.4M | $42.58 | -8.65% | United States |
| 609 | Akebia TherapeuticsAKBA | $121.3M | $0.44 | -36.97% | United States |
| 610 | Journey MedicalDERM | $121.2M | $4.30 | -9.20% | United States |
| 611 | Molecular PartnersMOLN | $120.6M | $3.22 | -1.98% | Switzerland |
| 612 | BGM GroupBGM | $118.9M | $8.90 | +2.89% | China |
| 613 | Coherus OncologyCHRS | $115.9M | $0.75 | -11.77% | United States |
| 614 | PolyPidPYPD | $114.8M | $5.65 | -2.89% | Israel |
| 615 | NkartaNKTX | $114.2M | $1.60 | -7.80% | United States |
| 616 | enGene TherapeuticsENGN | $113.6M | $1.70 | -1.45% | Canada |
| 617 | Foghorn TherapeuticsFHTX | $113.1M | $1.91 | -9.29% | United States |
| 618 | Cardiol TherapeuticsCRDL | $112.1M | $0.93 | -7.99% | Canada |
| 619 | Armata PharmaceuticalsARMP | $111.2M | $2.99 | -4.78% | United States |
| 620 | LifeMDLFMD | $110.6M | $2.30 | -6.33% | United States |
| 621 | Minerva NeurosciencesNERV | $109.8M | $2.30 | -10.53% | United States |
| 622 | PulmonxLUNG | $109.7M | $2.52 | -10.95% | United States |
| 623 | Kazia TherapeuticsKZIA | $109.7M | $7.06 | -12.69% | Australia |
| 624 | HumacyteHUMA | $108.3M | $0.39 | -13.33% | United States |
| 625 | OrganogenesisORGO | $107.9M | $0.84 | -3.62% | United States |
| 626 | Outlook TherapeuticsOTLK | $107.3M | $0.44 | -4.63% | United States |
| 627 | Voyager TherapeuticsVYGR | $106.0M | $1.72 | -8.02% | United States |
| 628 | Anixa BiosciencesANIX | $105.0M | $3.02 | -7.93% | United States |
| 629 | NovaBridge BiosciencesNBP | $104.8M | $0.91 | -10.10% | China |
| 630 | Airsculpt TechnologiesAIRS | $104.5M | $1.45 | -14.71% | United States |
| 631 | StereotaxisSTXS | $104.2M | $1.04 | +8.66% | United States |
| 632 | TuHURA BiosciencesHURA | $103.9M | $1.63 | -5.23% | United States |
| 633 | EquilliumEQ | $103.8M | $1.33 | -5.36% | United States |
| 634 | Anavex Life SciencesAVXL | $102.4M | $1.11 | -12.30% | United States |
| 635 | OnKure TherapeuticsOKUR | $102.3M | $2.53 | -2.51% | United States |
| 636 | NakamotoNAKA | $102.0M | $5.56 | -7.66% | United States |
| 637 | CellectisCLLS | $101.5M | $1.01 | -13.68% | France |
| 638 | ImmunicIMUX | $101.0M | $7.40 | -6.80% | United States |
| 639 | NRX PharmaceuticalsNRXP | $98.2M | $2.27 | -8.94% | United States |
| 640 | Park Dental PartnersPARK | $97.4M | $20.49 | -4.01% | United States |
| 641 | PMV PharmaceuticalsPMVP | $96.7M | $1.28 | -3.40% | United States |
| 642 | Unicycive TherapeuticsUNCY | $96.7M | $3.47 | -7.47% | United States |
| 643 | Black Diamond TherapeuticsBDTX | $95.7M | $1.67 | -12.37% | United States |
| 644 | LENZ TherapeuticsLENZ | $95.4M | $3.04 | -12.28% | United States |
| 645 | Neonc TechnologiesNTHI | $95.0M | $3.19 | +0.63% | United States |
| 646 | Vivani MedicalVANI | $94.7M | $1.05 | -1.87% | United States |
| 647 | Neumora TherapeuticsNMRA | $92.4M | $0.49 | -13.16% | United States |
| 648 | Perspective TherapeuticsCATX | $90.4M | $0.79 | -9.04% | United States |
| 649 | Polaryx TherapeuticsPLYX | $89.7M | $1.80 | +0.00% | United States |
| 650 | ImmucellICCC | $89.7M | $9.88 | -4.77% | United States |
| 651 | Lakeland IndustriesLAKE | $88.5M | $8.91 | -0.22% | United States |
| 652 | vTv TherapeuticsVTVT | $86.4M | $21.86 | -9.03% | United States |
| 653 | Milestone PharmaceuticalsMIST | $86.0M | $0.69 | -10.55% | Canada |
| 654 | RallybioRLYB | $84.7M | $15.74 | -1.01% | United States |
| 655 | Retension PharmaceuticalsRTSN | $83.4M | $10.58 | -8.75% | United States |
| 656 | Sera PrognosticsSERA | $82.5M | $2.08 | +2.98% | United States |
| 657 | GeneluxGNLX | $82.3M | $1.82 | -7.14% | United States |
| 658 | Ispire TechnologyISPR | $82.3M | $1.43 | -5.00% | United States |
| 659 | electroCoreECOR | $82.0M | $8.89 | +5.83% | United States |
| 660 | NyxoahNYXH | $81.3M | $0.81 | -5.42% | Belgium |
| 661 | Atara BiotherapeuticsATRA | $80.7M | $8.04 | -3.94% | United States |
| 662 | Lucid DiagnosticsLUCD | $79.6M | $0.39 | -12.02% | United States |
| 663 | Tiziana Life SciencesTLSA | $79.3M | $0.62 | -2.27% | United Kingdom |
| 664 | Insight Molecular DiagnosticsIMDX | $79.2M | $2.42 | -8.68% | United States |
| 665 | Tonix PharmaceuticalsTNXP | $79.0M | $4.61 | -9.88% | United States |
| 666 | Outset MedicalOM | $77.0M | $4.08 | -8.11% | United States |
| 667 | NeuraxisNRXS | $75.9M | $6.05 | -11.88% | United States |
| 668 | Cumberland PharmaceuticalsCPIX | $75.5M | $5.04 | +13.51% | United States |
| 669 | Fitlife BrandsFTLF | $75.1M | $8.00 | -1.84% | United States |
| 670 | OKYO PharmaOKYO | $73.5M | $1.40 | -2.10% | Guernsey |
| 671 | Tenaya TherapeuticsTNYA | $72.6M | $0.32 | -13.84% | United States |
| 672 | HyperfineHYPR | $72.6M | $0.68 | -8.76% | United States |
| 673 | MedicinovaMNOV | $71.9M | $1.46 | +0.69% | United States |
| 674 | Rani TherapeuticsRANI | $71.7M | $0.51 | -10.14% | United States |
| 675 | Microbot MedicalMBOT | $71.5M | $1.07 | -6.58% | Israel |
| 676 | Axe ComputeAGPU | $70.9M | $6.12 | -17.74% | United States |
| 677 | Basel Medical GroupBMGL | $70.9M | $5.22 | +0.58% | Singapore |
| 678 | SkinHealth SystemsSKIN | $67.9M | $10.43 | -5.61% | United States |
| 679 | Acrivon TherapeuticsACRV | $67.3M | $1.57 | -9.77% | United States |
| 680 | LensarLNSR | $67.2M | $5.47 | -6.34% | United States |
| 681 | NutriBandNTRB | $66.9M | $5.50 | -9.54% | United States |
| 682 | Zhengye BiotechnologyZYBT | $66.8M | $1.41 | +2.92% | China |
| 683 | Champions OncologyCSBR | $66.7M | $4.79 | -1.44% | United States |
| 684 | Coya TherapeuticsCOYA | $66.4M | $2.83 | -8.12% | United States |
| 685 | LifevantageLFVN | $66.0M | $5.25 | -12.14% | United States |
| 686 | Stablecoin DevelopmentSDEV | $65.7M | $0.90 | -7.08% | United States |
| 687 | MAIA BiotechnologyMAIA | $63.9M | $1.04 | -9.21% | United States |
| 688 | Conexeu SciencesCNXU | $63.4M | $2.09 | -5.86% | United States |
| 689 | CingulateCING | $61.4M | $4.22 | -7.46% | United States |
| 690 | Fortress BiotechFBIO | $61.4M | $1.84 | -6.60% | United States |
| 691 | Tenax TherapeuticsTENX | $61.2M | $1.64 | -9.67% | United States |
| 692 | Quantum CyberQUCY | $60.6M | $0.70 | -6.45% | Germany |
| 693 | Cognition TherapeuticsCGTX | $60.2M | $0.63 | -7.42% | United States |
| 694 | Spero TherapeuticsSPRO | $59.3M | $1.02 | -4.82% | United States |
| 695 | Cardiff OncologyCRDF | $58.9M | $0.76 | -12.80% | United States |
| 696 | Oncolytics BiotechONCY | $58.6M | $0.45 | +5.27% | Canada |
| 697 | Gossamer BioGOSS | $57.9M | $9.47 | -4.82% | United States |
| 698 | Telomir PharmaceuticalsTELO | $57.5M | $0.78 | -10.83% | United States |
| 699 | XBiotechXBIT | $57.0M | $1.87 | -4.10% | United States |
| 700 | ZeroStackZSTK | $56.7M | $2.60 | -4.06% | Canada |
Showing 601–700 of 1,019 companies. One row per company, with secondary share classes folded into their primary listing.
Industries in Health Care
Biotechnology: Pharmaceutical Preparations 498Biotechnology: Biological Products (No Diagnostic Substances) 163Medical Specialities 43Medical/Dental Instruments 124Medicinal Chemicals and Botanical Products 26Industrial Specialties 28Other Pharmaceuticals 10Hospital/Nursing Management 14Biotechnology: Electromedical & Electrotherapeutic Apparatus 26Biotechnology: Commercial Physical & Biological Resarch 12Biotechnology: In Vitro & In Vivo Diagnostic Substances 19Medical Electronics 4Ophthalmic Goods 8Medical/Nursing Services 29Misc Health and Biotechnology Services 10Precision Instruments 3Pharmaceuticals and Biotechnology 1Managed Health Care 1
Other sectors
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.